|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 326.00 EUR | -0.15% |
|
+1.72% | -8.81% |
| 07-14 | Where would AI lead Pharma in the long run? | ![]() |
| 06-19 | IBM Renews Its Partnership With France's Virbac |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 412 | +26.38% | 8 | |||||||
| 114.76 | +49.9% | 17 | |||||||
| 29.86 | +15.59% | 14 | |||||||
| 17.35 | +119.34% | 2 | |||||||
| 14.42 | +24.52% | 4 | |||||||
| 3.173 | +3.69% | 6 | |||||||
| - | 45.6 | +36.9% | 5 | ||||||
| 20.41 | +28.61% | 3 | |||||||
| 9 | +35.75% | 2 | |||||||
| 90.38 | +26.58% | 4 | |||||||
| 18.5 | +44.87% | 2 | |||||||
| 15.44 | +44.3% | 3 | |||||||
| 41.5 | +60.54% | 2 | |||||||
| - | - | - | 3.36 | +0.75% | 1 | ||||
| Average | 59.7 | +36.98% | 5 | ||||||
| Weighted average by Cap. | 91.57 | +41.92% | 13 |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

















